ACE2 and Onset: The expression of angiotensin-converting enzyme 2 (ACE2), the entry receptor for SARS-CoV-2, has been found not only in the respiratory system but also in extrapulmonary systems including the pancreas [2], raising concerns about new-onset diabetes after SARS-CoV-2 infection from the potential direct effect on pancreatic beta cells [3].